
| Code | Targets | Indications | Preclinical | IND | Ph I | Ph II | Ph III | NDA/BLA |
|---|---|---|---|---|---|---|---|---|
| UB642 | HBV preS1 | Hepatitis B chronic | ||||||
| UB522 | immune modulator | Hepatitis B chronic | ||||||
| UB349 | ASK-1 | Nonalcoholic steatohepatitis; Hepatic fibrosis | ||||||
| UB340 | TL1A | Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; Systemic sclerosis | ||||||
| UB100 | HBV | Chronic hepatitis B | ||||||
| UB063 | HBV Caspid | Chronic hepatitis B | ||||||
| UB049 | μ opioid receptor | Opioid-induced constipation | ||||||
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →